Vigabatrin for Treatment of Cocaine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

October 31, 2012

Conditions
Cocaine Dependence
Interventions
DRUG

vigabatrin

Tablets twice a day for 9 weeks

DRUG

placebo

tablets twice daily for 9 weeks

Trial Locations (11)

33161

Segal Institute for Clinical Research, North Miami

94110

St. Luke's Hospital Addiction Pharmacology Research Laboratory, San Francisco

Unknown

Addiction Treatment Clinic, Little Rock

Friends Research Institute, Torrance

Operation PAR, Largo

Johns Hopkins Bayview Medical Center Center for Chemical Dependence, Baltimore

Boston University School of Medicine, Boston

New York University Mental Health and Addictive Disorders Research Program, New York

Cincinnati Addiction Research Center (CinARC), Cincinnati

Dayton Veterans Affairs Medical Center, Dayton

University of Texas Health Science Center at San Antonio, San Antonio

Sponsors
All Listed Sponsors
lead

Catalyst Pharmaceuticals, Inc.

INDUSTRY

NCT00611130 - Vigabatrin for Treatment of Cocaine Dependence | Biotech Hunter | Biotech Hunter